
Indication
Treatment of ocular infections such as inclusion conjunctivitis, trachoma, meibomian gland dysfunction (MGD), ocular rosacea, and recurrent corneal erosion

Mechanism of Action
Inhibits protein synthesis, binding to the 30s ribosomal subunit of the mRNA. Inhibits production of metalloproteinases and other cytokines. May inhibit production of bacterial lipases.

Available Quantities
20 mg tablets, 100 mg tablets and capsules

Dosage/Instructions
Meibomian gland disease: 20mg – 50mg BID for 4 weeks then QD for another 4 to 8 weeks. Adult Inclusion Conjunctivitis: 100mg BID X 7 days. Recurrent Corneal Erosion: 50 to 100mg BID for 8 to 12 wks.

Pregnancy & Nursing
Tetracyclines can cause changes in both deciduous and permanent teeth during the time of tooth development; these changes include dysgenesis, staining, and an increased tendency to caries. Discoloration may be progressive and can vary from yellowish brown to dark gray. Because of bone growth depression and tooth discoloration, women in the last half of pregnancy, nursing mothers, and children under 8 years of age should avoid tetracyclines.

Pediatric Use
≥8 years

Contraindications, side effects, etc.
Contraindications: Hypersensitivity to doxycycline or other tetracyclines.
Warnings/Precautions: Avoid in children under 8 years old due to the risk of tooth discoloration. Use caution in patients with hepatic impairment or those taking hepatotoxic drugs. Photosensitivity is possible.
Common Side Effects: Gastrointestinal discomfort (nausea, vomiting, diarrhea), photosensitivity, rash, and rarely, esophageal ulceration and Clostridium difficile-associated diarrhea.